Coronary microvascular endothelial function deteriorates late (12 months) after sirolimus-eluting stent implantation

Journal of Cardiology

Volumn 56, Issue 2, 2010, Pages 229-235

  Miyamoto, Yoshinori ^a   Okura, Hiroyuki ^a   Kume, Teruyoshi ^a   Kawamoto, Takahiro ^a   Neishi, Yoji ^a   Hayashida, Akihiro ^a   Yamada, Ryotaro ^a   Imai, Koichiro ^a   Obase, Kikuko ^a   Yoshida, Kiyoshi ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Coronary artery disease; Endothelium function; Microcirculation; Stents

Indexed keywords

ACETYLSALICYLIC ACID; RAPAMYCIN; TICLOPIDINE;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY BLOOD VESSEL; DOPPLER ECHOCARDIOGRAPHY; DRUG ELUTING STENT; ENDOTHELIAL DYSFUNCTION; FEMALE; FLOW RATE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PERCUTANEOUS CORONARY INTERVENTION; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; BLOOD FLOW VELOCITY; CORONARY ANGIOGRAPHY; CORONARY VESSELS; DRUG-ELUTING STENTS; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOTHELIUM, VASCULAR; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MICROVESSELS; SIROLIMUS; STENTS; TIME FACTORS;

EID: 77956011605     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2010.05.007     Document Type: Article

References (30)

1. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caputo R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E. SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003, 349:1315-1323.
2. Fuke S., Maekawa K., Kawamoto K., Saito H., Sato T., Hioka T., Ohe T. Impaired endothelial vasomotor function after sirolimus-eluting stent implantation. Circ J 2007, 71:220-225.
3. Hofma S.H., van der Giessen W.J., van Dalen B.M., Lemos P.A., McFadden E.P., Sianos G., Ligthart J.M., van Essen D., de Feyter P.J., Serruys P.W. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation. Eur Heart J 2006, 27:166-170.
4. Togni M., Windecker S., Cocchia R., Wenaweser P., Cook S., Billinger M., Meier B., Hess O.M. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol 2005, 46:231-236.
5. Schwartz R.S., Chronos N.A., Virmani R. Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J Am Coll Cardiol 2004, 44:1373-1385.
6. McFadden E.P., Stabile E., Regar E., Cheneau E., Ong A.T., Kinnaird T., Suddath W.O., Weissman N.J., Torguson R., Kent K.M., Pichard A.D., Satler L.F., Waksman R., Serruys P.W. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004, 364:1519-1521.
7. Chammas E., Dib C., Rahhal M., Helou T., Ghanem G., Tarcha W. Noninvasive assessment of coronary flow reserve in the left anterior descending artery by transthoracic echocardiography before and after stenting. Echocardiography 2007, 24:789-794.
8. Reis S.E., Holubkov R., Lee J.S., Sharaf B., Reichek N., Rogers W.J., Walsh E.G., Fuisz A.R., Kerensky R., Detre K.M., Sopko G., Pepine C.J. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study. J Am Coll Cardiol 1999, 33:1469-1475.
9. Costa M.A., Angiolillo D.J., Tannenbaum M., Driesman M., Chu A., Patterson J., Kuehl W., Battaglia J., Dabbons S., Shamoon F., Flieshman B., Niederman A., Bass T.A. STLLR Investigators. Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial). Am J Cardiol 2008, 101:1704-1711.
10. Devereux R.B., Lutas E.M., Casale P.N., Kligfield P., Eisenberg R.R., Hammond I.W., Miller D.H., Reis G., Alderman M.H., Laragh J.H. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984, 4:1222-1230.
11. Kiviniemi T.O., Toikka J.O., Koskenvuo J.W., Saraste A., Saraste M., Parkka J.P., Raitakari O.T., Hartiala J.J. Vasodilation of epicardial coronary artery can be measured with transthoracic echocardiography. Ultrasound Med Biol 2007, 33:362-370.
12. Koskenvuo J.W., Saraste M., Niemi P., Knuuti J., Sakuma H., Toikka J.O., Komu M., Jarvisalo M.J., Hartiala J.J. Correlation of transthoracic Doppler echocardiography and magnetic resonance imaging in measuring left anterior descending artery flow velocity and time-course of dipyridamole-induced coronary flow increase. Scand J Clin Lab Invest 2003, 63:65-72.
13. Serry R., Penny W.F. Endothelial dysfunction after sirolimus-eluting stent placement. J Am Coll Cardiol 2005, 46:237-238.
14. Shin D.I., Kim P.J., Seung K.B., Kim D.B., Kim M.J., Chang K., Lim S.M., Jeon D.S., Chung W.S., Baek S.H., Lee M.Y. Drug-eluting stent implantation could be associated with long-term coronary endothelial dysfunction. Int Heart J 2007, 48:553-567.
15. Maekawa K., Kawamoto K., Fuke S., Yoshioka R., Saito H., Sato T., Hioka T. Images in cardiovascular medicine. Severe endothelial dysfunction after sirolimus-eluting stent implantation. Circulation 2006, 113:e850-e851.
16. Murakami D., Takano M., Yamamoto M., Inami S., Ohba T., Seino Y., Mizuno K. Novel neointimal formation over sirolimus-eluting stents identified by coronary angioscopy and optical coherence tomography. J Cardiol 2009, 53:311-313.
17. Kuroda N., Kobayashi Y., Nameki M., Kuriyama N., Kinoshita T., Okuno T., Yamamoto Y., Komiyama N., Masuda Y. Intimal hyperplasia regression from 6 to 12 months after stenting. Am J Cardiol 2002, 89:869-872.
18. Kimura T., Yokoi H., Nakagawa Y., Tamura T., Kaburagi S., Sawada Y., Sato Y., Yokoi H., Hamasaki N., Nosaka H., Nobuyoshi M. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med 1996, 334:561-566.
19. Neishi Y., Akasaka T., Tsukiji M., Kume T., Wada N., Watanabe N., Kawamoto T., Kaji S., Yoshida K. Reduced coronary flow reserve in patients with congestive heart failure assessed by transthoracic Doppler echocardiography. J Am Soc Echocardiogr 2005, 18:15-19.
20. Pandian N.G., Skorton D.J., Kieso R.A., Kerber R.E. Diagnosis of constrictive pericarditis by two-dimensional echocardiography: studies in a new experimental model and in patients. J Am Coll Cardiol 1984, 4:1164-1173.
21. Appleton C.P., Hatle L.K., Popp R.L. Demonstration of restrictive ventricular physiology by Doppler echocardiography. J Am Coll Cardiol 1988, 11:757-768.
22. Akasaka T., Yoshikawa J., Yoshida K., Maeda K., Takagi T., Miyake S. Phasic coronary flow characteristics in patients with hypertrophic cardiomyopathy: a study by coronary Doppler catheter. J Am Soc Echocardiogr 1994, 7:9-19.
23. Shimokawa H. Primary endothelial dysfunction: atherosclerosis. J Mol Cell Cardiol 1999, 31:23-37.
24. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
25. Finn A.V., Nakazawa G., Joner M., Kolodgie F.D., Mont E.K., Gold H.K., Virmani R. Vascular responses to drug eluting stents: importance of delayed healing. Arterioscler Thromb Vasc Biol 2007, 27:1500-1510.
26. Kotani J., Awata M., Nanto S., Uematsu M., Oshima F., Minamiguchi H., Mintz G.S., Nagata S. Incomplete neointimal coverage of sirolimus-eluting stents: angioscopic findings. J Am Coll Cardiol 2006, 47:2108-2111.
27. Ohtani T., Ueda Y., Shimizu M., Mizote I., Hirayama A., Hori M., Kodama K. Association between cardiac troponin T elevation and angioscopic morphology of culprit lesion in patients with non-ST-segment elevation acute coronary syndrome. Am Heart J 2005, 150:227-233.
28. Kawata T., Daimon M., Hasegawa R., Teramoto K., Toyoda T., Sekine T., Yamamoto K., Uchida D., Himi T., Yoshida K., Komuro I. Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonist. Am Heart J 2006, 151. 798, e9-15.
29. Kamezaki F., Tasaki H., Yamashita K., Shibata K., Hirakawa N., Tsutsui M., Kouzuma R., Nagatomo T., Adachi T., Otsuji Y. Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: comparison with calcium channel blocker. Hypertens Res 2007, 30:699-706.
30. Nikolaidis L.A., Doverspike A., Huerbin R., Hentosz T., Shannon R.P. Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism. Circulation 2002, 105:2785-2790.